RxDoctor Payments Data

Clayton Howell

Family Medicine · Tulsa, OKNPI 1407113780

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 24.7% of the total. Reporting peaked in 2022 at $654 and has fallen 97.4% since, to $17 in 2023.

$1,870in general payments, 2019–2025

Across 125 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$461
  • Boehringer Ingelheim$428
  • GSK$139
  • Pfizer$96
  • Lilly USA, LLC$88
  • Novartis$73
  • plus $584 from 16 others

What the payments were for

  • Food & beverage$1,85899%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,870 in reported general payments places this provider in the 70th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma →

Other family medicine in Tulsa

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →